TY - JOUR
T1 - Spatial epigenome–transcriptome co-profiling of mammalian tissues
AU - Zhang, Di
AU - Deng, Yanxiang
AU - Kukanja, Petra
AU - Agirre, Eneritz
AU - Bartosovic, Marek
AU - Dong, Mingze
AU - Ma, Cong
AU - Ma, Sai
AU - Su, Graham
AU - Bao, Shuozhen
AU - Liu, Yang
AU - Xiao, Yang
AU - Rosoklija, Gorazd B.
AU - Dwork, Andrew J.
AU - Mann, J. John
AU - Leong, Kam W.
AU - Boldrini, Maura
AU - Wang, Liya
AU - Haeussler, Maximilian
AU - Raphael, Benjamin J.
AU - Kluger, Yuval
AU - Castelo-Branco, Gonçalo
AU - Fan, Rong
N1 - Funding Information:
We thank the Yale Center for Research Computing for guidance and use of the research computing infrastructure. The moulds for microfluidic devices were fabricated at the Yale University School of Engineering and Applied Science Nanofabrication Center. NGS was conducted at the Yale Center for Genome Analysis and at the Yale Stem Cell Center Genomics Core Facility, supported by the Connecticut Regenerative Medicine Research Fund and the Li Ka Shing Foundation. Service provided by the Genomics Core of Yale Cooperative Center of Excellence in Hematology (no. U54DK106857) was used. We thank T. Jimenez-Beristain for writing laboratory animal ethics permits and assistance with animal experiments, and the staff at Comparative Medicine-Biomedicum. M. Bartosovic was funded by the Vinnova Seal of Excellence Marie-Sklodowska Curie Actions grant RNA-centric view on oligodendrocyte lineage development (RODent). E.A. was funded by the European Union, Horizon 2020, Marie-Sklodowska Curie Actions and the grant SOLO (no. 794689). Work in G.C.-B.’s research group was supported by the Swedish Research Council (grant no. 2019-01360), the Swedish Cancer Society (Cancerfonden, no. 190394 Pj), the Knut and Alice Wallenberg Foundation (grant nos. 2019-0107 and 2019-0089), The Swedish Society for Medical Research (grant no. JUB2019), the Göran Gustafsson Foundation for Research in Natural Sciences and Medicine, the Ming Wai Lau Centre for Reparative Medicine and Karolinska Institutet. This research was supported by Packard Fellowship for Science and Engineering (to R.F.), Yale Stem Cell Center Chen Innovation Award (to R.F.) and the US National Institutes of Health (nos. RF1MH128876, U54AG076043, U54AG079759, UG3CA257393, UH3CA257393, R01CA245313 and U54CA274509 to R.F.). Y.L. was supported by the Society for ImmunoTherapy of Cancer Fellowship.
Funding Information:
We thank the Yale Center for Research Computing for guidance and use of the research computing infrastructure. The moulds for microfluidic devices were fabricated at the Yale University School of Engineering and Applied Science Nanofabrication Center. NGS was conducted at the Yale Center for Genome Analysis and at the Yale Stem Cell Center Genomics Core Facility, supported by the Connecticut Regenerative Medicine Research Fund and the Li Ka Shing Foundation. Service provided by the Genomics Core of Yale Cooperative Center of Excellence in Hematology (no. U54DK106857) was used. We thank T. Jimenez-Beristain for writing laboratory animal ethics permits and assistance with animal experiments, and the staff at Comparative Medicine-Biomedicum. M. Bartosovic was funded by the Vinnova Seal of Excellence Marie-Sklodowska Curie Actions grant RNA-centric view on oligodendrocyte lineage development (RODent). E.A. was funded by the European Union, Horizon 2020, Marie-Sklodowska Curie Actions and the grant SOLO (no. 794689). Work in G.C.-B.’s research group was supported by the Swedish Research Council (grant no. 2019-01360), the Swedish Cancer Society (Cancerfonden, no. 190394 Pj), the Knut and Alice Wallenberg Foundation (grant nos. 2019-0107 and 2019-0089), The Swedish Society for Medical Research (grant no. JUB2019), the Göran Gustafsson Foundation for Research in Natural Sciences and Medicine, the Ming Wai Lau Centre for Reparative Medicine and Karolinska Institutet. This research was supported by Packard Fellowship for Science and Engineering (to R.F.), Yale Stem Cell Center Chen Innovation Award (to R.F.) and the US National Institutes of Health (nos. RF1MH128876, U54AG076043, U54AG079759, UG3CA257393, UH3CA257393, R01CA245313 and U54CA274509 to R.F.). Y.L. was supported by the Society for ImmunoTherapy of Cancer Fellowship.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/4/6
Y1 - 2023/4/6
N2 - Emerging spatial technologies, including spatial transcriptomics and spatial epigenomics, are becoming powerful tools for profiling of cellular states in the tissue context1–5. However, current methods capture only one layer of omics information at a time, precluding the possibility of examining the mechanistic relationship across the central dogma of molecular biology. Here, we present two technologies for spatially resolved, genome-wide, joint profiling of the epigenome and transcriptome by cosequencing chromatin accessibility and gene expression, or histone modifications (H3K27me3, H3K27ac or H3K4me3) and gene expression on the same tissue section at near-single-cell resolution. These were applied to embryonic and juvenile mouse brain, as well as adult human brain, to map how epigenetic mechanisms control transcriptional phenotype and cell dynamics in tissue. Although highly concordant tissue features were identified by either spatial epigenome or spatial transcriptome we also observed distinct patterns, suggesting their differential roles in defining cell states. Linking epigenome to transcriptome pixel by pixel allows the uncovering of new insights in spatial epigenetic priming, differentiation and gene regulation within the tissue architecture. These technologies are of great interest in life science and biomedical research.
AB - Emerging spatial technologies, including spatial transcriptomics and spatial epigenomics, are becoming powerful tools for profiling of cellular states in the tissue context1–5. However, current methods capture only one layer of omics information at a time, precluding the possibility of examining the mechanistic relationship across the central dogma of molecular biology. Here, we present two technologies for spatially resolved, genome-wide, joint profiling of the epigenome and transcriptome by cosequencing chromatin accessibility and gene expression, or histone modifications (H3K27me3, H3K27ac or H3K4me3) and gene expression on the same tissue section at near-single-cell resolution. These were applied to embryonic and juvenile mouse brain, as well as adult human brain, to map how epigenetic mechanisms control transcriptional phenotype and cell dynamics in tissue. Although highly concordant tissue features were identified by either spatial epigenome or spatial transcriptome we also observed distinct patterns, suggesting their differential roles in defining cell states. Linking epigenome to transcriptome pixel by pixel allows the uncovering of new insights in spatial epigenetic priming, differentiation and gene regulation within the tissue architecture. These technologies are of great interest in life science and biomedical research.
UR - http://www.scopus.com/inward/record.url?scp=85149906363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149906363&partnerID=8YFLogxK
U2 - 10.1038/s41586-023-05795-1
DO - 10.1038/s41586-023-05795-1
M3 - Article
C2 - 36922587
AN - SCOPUS:85149906363
SN - 0028-0836
VL - 616
SP - 113
EP - 122
JO - Nature
JF - Nature
IS - 7955
ER -